Cargando…
Cannabis/Cannabinoids for Treating COVID-19 Associated Neuropsychiatric Complications
COVID-19 epidemic has resulted in devastating mortality and morbidity consisting of socioeconomic and health effects that have included respiratory/pulmonary, cardiovascular, mental health and neurological consequences such as anxiety, depression, and substance use. Several effective vaccines have b...
Autores principales: | Khalsa, Jag H., Maggirwar, Sanjay B., Bunt, Greg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520083/ https://www.ncbi.nlm.nih.gov/pubmed/34655372 http://dx.doi.org/10.1007/s11481-021-10013-8 |
Ejemplares similares
-
Review: Cannabinoids as Medicinals
por: Khalsa, Jag H., et al.
Publicado: (2022) -
The Link between Cannabis Use, Immune System, and Viral Infections
por: Maggirwar, Sanjay B., et al.
Publicado: (2021) -
The legalization of cannabinoid products and standardizing cannabis-drug development
in the United States: a brief report
por: Marcu, Jahan
Publicado: (2020) -
Long-term Neuropsychiatric Complications and (18)F-FDG-PET Hypometabolism in the Brain From Prolonged Infection of COVID-19
por: Yu, Allen T., et al.
Publicado: (2022) -
Society on NeuroImmune Pharmacology COVID-19 Virtual Workshop
por: Kumar, Santosh, et al.
Publicado: (2021)